Discover
PCVX
Vaxcyte, Inc.
58.04
1 x 57.28
1 x 59.94
bid
ask
+
2.54
4.58%
1 @ 04:00 PM
58.00 -0.04 (0.07%)
| Ytd | 25.79% | |
| 1y | 62.85% |
55.44
day range
58.19
29.08
52 week range
65.00
| Open | 55.54 | Prev Close | 55.50 | Low | 55.44 | High | 58.19 | Mkt Cap | 8.38B |
| Vol | 852.77K | Avg Vol | 1.59M | EPS | -6.88 | P/E | -8.44 | Forward P/E | -7.84 |
| Beta | 1.22 | Short Ratio | 8.98 | Inst. Own | 113.91% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 52.52 | 200-d Avg | 51.54 | 1yr Est | 109.00 |
| Income Statement | |||
| Operating Expenses | 345.85M | ||
| Research and Development Expense | 312.78M | ||
| Selling, General and Administrative Expense | 33.07M | ||
| Operating Income | -345.85M | ||
| Net Income | -320.62M | ||
| Net Income Common Stock | -320.62M | ||
| Net Income Common Stock (USD) | -320.62M | ||
| Consolidated Income | -320.62M | ||
| Earnings per Basic Share | -2.30 | ||
| Earnings per Basic Share (USD) | -2.30 | ||
| Earnings per Diluted Share | -2.30 | ||
| Earning Before Interest & Taxes (EBIT) | -320.62M | ||
| Earning Before Interest & Taxes (USD) | -320.62M | ||
| Weighted Average Shares | 139.51M | ||
| Weighted Average Shares Diluted | 139.51M | ||
| Balance Sheet | |||
| Cash and Equivalents | 260.84M | ||
| Cash and Equivalents (USD) | 260.84M | ||
| Investments | 2.48B | ||
| Investments Current | 1.48B | ||
| Investments Non-Current | 1.01B | ||
| Current Assets | 1.81B | ||
| Property, Plant & Equipment Net | 373.80M | ||
| Total Assets | 3.35B | ||
| Debt Current | 6.09M | ||
| Total Debt | 116.30M | ||
| Current Liabilities | 242.08M | ||
| Debt Non-Current | 110.21M | ||
| Total Liabilities | 352.29M | ||
| Accumulated Retained Earnings (Deficit) | -2.48B | ||
| Accumulated Other Comprehensive Income | -6.83M | ||
| Shareholders Equity | 3.00B | ||
| Shareholders Equity (USD) | 3.00B | ||
| Assets Non-Current | 1.53B | ||
| Total Debt (USD) | 116.30M | ||
| Liabilities Non-Current | 110.21M | ||
| Trade and Non-Trade Payables | 63.06M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.85M | ||
| Net Cash Flow from Financing | 601.58M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 86.88M | ||
| Capital Expenditure | -14.79M | ||
| Issuance (Purchase) of Equity Shares | 610.88M | ||
| Net Cash Flow from Investing | -233.41M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -218.62M | ||
| Net Cash Flow from Operations | -280.62M | ||
| Effect of Exchange Rate Changes on Cash | -664.00K | ||
| Share Based Compensation | 37.96M | ||